+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

United States Cardiovascular Surgery Devices Market Outlook to 2033 - Beating Heart Surgery Systems and Perfusion Disposables

  • PDF Icon

    Report

  • 45 Pages
  • September 2025
  • Region: United States
  • GlobalData
  • ID: 5999265
The “United States Cardiovascular Surgery Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Cardiovascular Surgery Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Beating Heart Surgery Systems and Perfusion Disposables

The United States Cardiovascular Surgery Devices Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2023 company share data for Cardiovascular Surgery Devices Market.
  • Global corporate-level profiles of key companies operating within the United States Cardiovascular Surgery Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Cardiovascular Surgery Devices is segmented as follows:

  • Beating Heart Surgery Systems
  • Perfusion Disposables

Reasons to Buy

The United States Cardiovascular Surgery Devices Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Cardiovascular Surgery Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Cardiovascular Surgery Devices Market, United States
3.1 Cardiovascular Surgery Devices Market, United States, Revenue ($m), 2018-2033
3.1.1 Beating Heart Surgery Systems Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Perfusion Disposables Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Cardiovascular Surgery Devices Market, United States, Volume (Units), 2018-2033
3.2.1 Beating Heart Surgery Systems Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Perfusion Disposables Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Cardiovascular Surgery Devices Market, United States, Average Price ($), 2018-2033
3.4 Cardiovascular Surgery Devices Market, United States, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United States, Cardiovascular Surgery Devices Market
4.1 Abbott Laboratories
4.1.1 Company Overview
4.2 Getinge AB
4.2.1 Company Overview
4.3 LivaNova Plc
4.3.1 Company Overview
4.4 Medtronic Plc
4.4.1 Company Overview
4.5 Terumo Corp
4.5.1 Company Overview
4.6 Nipro Corp
4.6.1 Company Overview
4.7 Fresenius SE & Co KGaA
4.7.1 Company Overview
4.8 Edwards Lifesciences Corp
4.8.1 Company Overview
4.9 MicroPort Scientific Corp
4.9.1 Company Overview
5 Cardiovascular Surgery Devices Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Sanner Acquires Gilero
7 Recent Developments
7.1 Corporate Communications
7.1.1 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
7.1.2 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
7.2 Financial Announcements
7.2.1 Jul 18, 2025: Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025
7.2.2 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
7.2.3 Apr 18, 2025: Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025
7.2.4 Apr 07, 2025: LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025
7.2.5 Feb 04, 2025: Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025
7.2.6 Feb 04, 2025: Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025
7.2.7 Oct 31, 2024: LeMaitre Reports Q3 2024 Results
7.2.8 Oct 30, 2024: MIMEDX Reports Q3 2024 Operating and Financial Results
7.2.9 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024
7.2.10 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024
7.2.11 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results
7.3 Government and Public Interest
7.3.1 Jul 30, 2025: Artivion to Participate in Upcoming Investor Conferences
7.3.2 Apr 01, 2025: LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference
7.3.3 Nov 21, 2024: Trawick International Enhances Global Medical Coverage with Access to Cleveland Clinic World-Renowned Care
7.4 Product News
7.4.1 Feb 19, 2025: Chlorine Dioxide Debuts in Updated Standards for Healthcare Sterilants and High-Level Disinfectants
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Cardiovascular Surgery Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Cardiovascular Surgery Devices Market, United States, Volume (Units), 2018-2033
Table 5: Beating Heart Surgery Systems Market, United States, Volume (Units), 2018-2033
Table 6: Perfusion Disposables Market, United States, Volume (Units), 2018-2033
Table 7: Cardiovascular Surgery Devices Market, United States, Average Price ($), 2018-2033
Table 8: Cardiovascular Surgery Devices Market, United States, Company Share by Revenue ($m), 2024
Table 9: Cardiovascular Surgery Devices Market Pipeline Products
Table 10: Sanner Acquires Gilero
Table 11: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
List of Figures
Figure 1: Cardiovascular Surgery Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Cardiovascular Surgery Devices Market, United States, Volume (Units), 2018-2033
Figure 5: Beating Heart Surgery Systems Market, United States, Volume (Units), 2018-2033
Figure 6: Perfusion Disposables Market, United States, Volume (Units), 2018-2033
Figure 7: Cardiovascular Surgery Devices Market, United States, Company Share (%), 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Getinge AB
  • LivaNova PLC
  • Medtronic Plc
  • Terumo Corp
  • Nipro Corp
  • Fresenius SE & Co KGaA
  • Edwards Lifesciences Corp
  • MicroPort Scientific Corp